Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A R D Delbridge
The BCL-2 Protein Family, BH3-mimetics and Cancer Therapy
Cell Death and Differentiation
Cell Biology
Molecular Biology
Related publications
Targeting the BCL-2 Family for Cancer Therapy
Expert Opinion on Therapeutic Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
BH3 Mimetics: Their Action and Efficacy in Cancer Chemotherapy
Integrative Cancer Science and Therapeutics
Bfk: A Novel Weakly Proapoptotic Member of the BCL-2 Protein Family With a BH3 and a BH2 Region
Cell Death and Differentiation
Cell Biology
Molecular Biology
Combining Bh3-Mimetics to Target Both BCL-2 and McL1 Has Potent Activity in Pre-Clinical Models of Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Multimodal Targeting of the BCL-2 Family in Cancer
AACR Education book
BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The BCL-2 Homology Domain 3 (BH3)-only Proteins Bim and Bid Are Functionally Active and Restrained by Anti-Apoptotic BCL-2 Family Proteins in Healthy Liver
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Prognostic Impact of the Expression/Phosphorylation of the BH3-only Proteins of the BCL-2 Family in Glioblastoma Multiforme
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
High Expression of BCL-2 and BCL-Xl in Diffuse Large B-Cell Lymphoma Confer Poor Prognosis but May Be Reversible by Combined Inhibition With Bet Inhibitors and Bh3 Mimetics.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
